The path to healthy ageing in China: a Peking University–Lancet Commission

Chen, Xinxin; Giles, John; Yao, Yao; Yip, Winnie; Meng, Qinqin; Berkman, Lisa F.; Chen, He; Chen, Xi; Jin, Feng; Feng, Zhanlian; Glinskaya, Elena; Gong, Jinquan; Hu, Perry; Kan, Haidong; Lei, Xiaoyan; Liu, Xiao; Steptoe, Andrew; Wang, Gewei; Wang, Harold; Wang, Huali; Wang, Xiaoyu; Wang, Yafeng; Li, Yang; Zhang, Luxia; Zhang, Quan; Wu, Jing; Wu, Zunyou; Strauss, John; Smith, James P.; Zhao, Yaohui

doi:10.1016/s0140-6736(22)01546-x

Cited by 293 publications

(132 citation statements)

References 202 publications

Supporting

Mentioning

129

Contrasting

Order By: Relevance

“…China has the largest number of older individuals globally 8 . Fearing the catastrophe for the older population under a less developed medical infrastructure, China adhered to a zero-COVID strategy for nearly three years until November 2022, effectively shielding the population against COVID-19.…”

Section: Introductionmentioning

confidence: 99%

Determinants of COVID-19 vaccination status and hesitancy among older adults in China

Wang

Yao

Wang

et al. 2023

Nat Med

View full text Add to dashboard Cite

Vaccination is the primary defence against SARS-CoV-2, especially among the elderly and those with chronic conditions. Using a nationally representative sample of 12,900 participants from the fifth wave (2021-22) of the China Health and Retirement Longitudinal Study (CHARLS), we examined the COVID-19 vaccination status and the determinants of vaccination hesitancy in Chinese adults 52 and older. By July-August of 2022, 92.3% of the Chinese population 60 years and older had received at least one COVID-19 vaccination, 88.6% completed the primary series, and 72.4% received a booster. Those aged 80 years and older had lower vaccination rates, with 71.9% and 46.7% completed the primary series and booster shots, respectively. These statistics represented the situation before China ended the Zero-Covid policy in November 2022 because vaccination stagnated between July-August and November.Multivariate regressions revealed that oldest age groups (70 and older, especially 80 and older), female, unmarried, urban residents, functionally dependent, and with chronic conditions were less likely to receive COVID-19 vaccines. Our regression results were corroborated by self-reported reasons for non-vaccination. Vaccination hesitancy has likely contributed to excessive mortality among the vulnerable populations after China ceased its zero-COVID practice. Our study provides important lessons on how to balance containment efforts with vaccination and treatment measures, and on the need to clarify vaccine's side effects and contraindications early on.

show abstract

Section: Introductionmentioning

confidence: 99%

Determinants of COVID-19 vaccination status and hesitancy among older adults in China

Wang

Yao

Wang

et al. 2023

Nat Med

View full text Add to dashboard Cite

show abstract

“…The projected large increases in care needs emphasise the importance of promoting healthy ageing and building an age-friendly environment as a national strategy for reducing the burden of population ageing. 28 China also needs to strengthen its aged-care sector to prepare for increases in the number of older people needing care. Future research should closely monitor the trends in older people's functional dependency, the improvement in age-friendly facilities, and whether care needs are met.…”

Section: Discussionmentioning

confidence: 99%

Nowcasting and forecasting the care needs of the older population in China: analysis of data from the China Health and Retirement Longitudinal Study (CHARLS)

Gong

Wang²,

Wang³

et al. 2022

The Lancet Public Health

Self Cite

105

View full text Add to dashboard Cite

“…With the 2020 China Census showing that China already has the largest elderly population in the world and is rapidly entering deep aging, the burden of aging in China is set to increase further ( 38 ). The health of older people is the most prominent issue in an aging society, and over the past three decades China has completed an epidemiological transition from communicable to non-communicable diseases ( 39 ). There are currently about 140 million elderly people with hypertension in China, making it the most prevalent chronic non-communicable disease among the elderly in China.…”

Section: Discussionmentioning

confidence: 99%

A study on the prevalence and related factors of frailty and pre-frailty in the older population with hypertension in China: A national cross-sectional study

Zeng

Jia

Meng

et al. 2023

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

ObjectiveTo explore the prevalence and factors associated with frailty and pre-frailty in elderly Chinese patients with hypertension.BackgroundIn China, there have been few national studies into the prevalence and factors associated with frailty and pre-frailty in elderly patients with hypertension.MethodsThrough the 4th Sample Survey of Aged Population in Urban and Rural China (SSAPUR) in 2015, the situation of hypertension subjects aged 60 years or older in 31 provinces, autonomous regions, and municipalities in mainland China was obtained. And the frailty index was constructed based on 33 potential defects, elderly hypertensive patients are classified as robust, frailty, and pre-frailty.ResultsA total of 76,801 elderly patients with hypertension were enrolled in the study. The age-sex standardized prevalence of frailty and pre-frailty in hypertensive elderly in China was 16.1% (95%CI 15.8–16.3%), 58.1% (95%CI 57.7–58.4%). There were significant geographical differences in the prevalence of frailty and pre-frailty in elderly hypertensive patients. Multinomial logistic regression analysis showed that poor economic status, activities of daily living disability, and comorbid chronic diseases were related to frailty and pre-frailty.ConclusionFrailty and pre-frailty are very common in elderly Chinese patients with hypertension and have similar risk factors. Prevention strategies should be developed to stop or delay the onset of frailty by targeting established risk factors in the pre-frailty population of elderly hypertension. It is also crucial to optimize the management of frailty in elderly Chinese patients with hypertension.

show abstract

The path to healthy ageing in China: a Peking University–Lancet Commission

Cited by 293 publications

References 202 publications

Determinants of COVID-19 vaccination status and hesitancy among older adults in China

Determinants of COVID-19 vaccination status and hesitancy among older adults in China

Nowcasting and forecasting the care needs of the older population in China: analysis of data from the China Health and Retirement Longitudinal Study (CHARLS)

A study on the prevalence and related factors of frailty and pre-frailty in the older population with hypertension in China: A national cross-sectional study

Contact Info

Product

Resources

About